Clinical Trials Browser

Phase 2 × Pancreatic Neoplasms × Injections × Clear all

NCT05616494 2023-03-22

A Study of Docetaxel for Injection (Albumin-bound) in Patients With Pancreatic Cancer

Phase 2 Unknown

Gastrointestinal

Pancreatic Neoplasms